Anecortave acetate is a unique ocular angiostatic cortisene that has broad-based anti-angiogenic activity in 14 different preclinical models of neovascularization, across multiple species and inducers of neovascularization. Anecortave acetate is being tested clinically for inhibition of choroidal neovascularization associated with age-related macular degeneration.
|Journal||Survey of Ophthalmology|
|Issue number||1 SUPPL.|
|State||Published - 1 Jan 2007|
- age-related macular degeneration
- anecortave acetate
- choroidal neovascularization